BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3825996)

  • 1. Prognostic factors in early carcinoma of the endometrium.
    Genest P; Drouin P; Gerig L; Girard A; Stewart D; Prefontaine M
    Am J Clin Oncol; 1987 Feb; 10(1):71-7. PubMed ID: 3825996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage II endometrial carcinoma: prognostic factors and the results of treatment.
    Andersen ES
    Gynecol Oncol; 1990 Aug; 38(2):220-3. PubMed ID: 2387540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in stage II endometrial carcinoma.
    Larson DM; Copeland LJ; Gallager HS; Wharton JT; Gershenson DM; Edwards CL; Malone JM; Rutledge FN
    Cancer; 1987 Sep; 60(6):1358-61. PubMed ID: 3621118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage III carcinoma of the endometrium: a review of 41 cases.
    Genest P; Drouin P; Girard A; Gerig L
    Gynecol Oncol; 1987 Jan; 26(1):77-86. PubMed ID: 3792938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors in cancer of the endometrium and therapeutic indications].
    Fossat C; Mage P; Marée D; Avril A; Pigneux J; Richaud P
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(5):573-8. PubMed ID: 6491199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical stage I and II endometrial carcinoma treated with surgery and/or radiation therapy: analysis of prognostic and treatment-related factors.
    Bucy GS; Mendenhall WM; Morgan LS; Chafe WE; Wilkinson EJ; Marcus RB; Million RR
    Gynecol Oncol; 1989 Jun; 33(3):290-5. PubMed ID: 2722051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases.
    Black C; Feng A; Bittinger S; Quinn M; Neesham D; McNally O
    Int J Gynecol Cancer; 2016 Jan; 26(1):133-40. PubMed ID: 26588230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of stage II endometrial carcinoma.
    Boothby RA; Carlson JA; Neiman W; Rubin MM; Morgan MA; Schultz D; Mikuta JJ
    Gynecol Oncol; 1989 May; 33(2):204-8. PubMed ID: 2495242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage III carcinoma of the endometrium. Results of treatment.
    Ahmad K; Kim YH; Deppe G; Malone J; Hegarty T; Malviya V; Herskovic A; Ratanatharathorn V; Sakr WA; Medina A
    Eur J Gynaecol Oncol; 1989; 10(6):383-9. PubMed ID: 2697570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment failure in endometrial carcinoma.
    Burke TW; Heller PB; Woodward JE; Davidson SA; Hoskins WJ; Park RC
    Obstet Gynecol; 1990 Jan; 75(1):96-101. PubMed ID: 2296431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.
    Morrow CP; Bundy BN; Kurman RJ; Creasman WT; Heller P; Homesley HD; Graham JE
    Gynecol Oncol; 1991 Jan; 40(1):55-65. PubMed ID: 1989916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined surgery and radiation in endometrial carcinoma: an analysis of prognostic factors.
    Nori D; Hilaris BS; Tome M; Lewis JL; Birnbaum S; Fuks Z
    Int J Radiat Oncol Biol Phys; 1987 Apr; 13(4):489-97. PubMed ID: 3104248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma.
    Sood BM; Jones J; Gupta S; Khabele D; Guha C; Runowicz C; Goldberg G; Fields A; Anderson P; Vikram B
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):208-16. PubMed ID: 12909235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage II carcinoma of the endometrium: results of therapy and prognostic factors.
    Grigsby PW; Perez CA; Camel HM; Kao MS; Galakatos AE
    Int J Radiat Oncol Biol Phys; 1985 Nov; 11(11):1915-23. PubMed ID: 4055452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma.
    Carcangiu ML; Chambers JT
    Gynecol Oncol; 1992 Dec; 47(3):298-305. PubMed ID: 1473741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of failure patterns in stage III endometrial carcinoma and therapeutic implications.
    Greven KM; Curran WJ; Whittington R; Fanning J; Randall ME; Wilder J; Peters AJ
    Int J Radiat Oncol Biol Phys; 1989 Jul; 17(1):35-9. PubMed ID: 2745205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoma of the endometrium.
    Glassburn JR
    Cancer; 1981 Jul; 48(2 Suppl):575-81. PubMed ID: 7023666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenocarcinoma of the endometrium stage I. Treatment, survival and recurrence.
    Philipsen T; Nørgård M
    Acta Obstet Gynecol Scand; 1984; 63(1):51-5. PubMed ID: 6720256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is vascular and lymphatic space invasion a main prognostic factor in uterine neoplasms with a sarcomatous component? A retrospective study of prognostic factors of 60 patients stratified by stages.
    Rovirosa A; Ascaso C; Ordi J; Abellana R; Arenas M; Lejarcegui JA; Pahisa J; Puig-Tintoré LM; Mellado B; Armenteros B; Iglesias X; Biete A
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1320-9. PubMed ID: 11955745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphadenectomy as a prognostic marker in uterine non-endometrioid carcinoma.
    Mylonas I; Schindlbeck C
    Arch Gynecol Obstet; 2012 Jan; 285(1):207-14. PubMed ID: 21538008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.